Back to Search
Start Over
Polymorphisms in Plasmodium falciparum Kelch 13 and P. vivax Kelch 12 Genes in Parasites Collected from Three South Pacific Countries Prior to Extensive Exposure to Artemisinin Combination Therapies.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Jun 24; Vol. 63 (7). Date of Electronic Publication: 2019 Jun 24 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- The South Pacific countries Solomon Islands, Vanuatu, and Papua New Guinea (PNG) adopted artemisinin-based combination therapies (ACTs) in 2008. We examined Kelch 13 and Kelch 12 genes in parasites originating from these countries before or at ACT introduction. Four Kelch 13 and two Kelch 12 novel sequence polymorphisms, not associated with artemisinin resistance, were observed in parasites from Solomon Islands and Vanuatu. No polymorphisms were observed in PNG parasites. The findings provide useful baseline information.<br /> (Copyright © 2019 American Society for Microbiology.)
- Subjects :
- Animals
Antimalarials therapeutic use
Artemisinins therapeutic use
Drug Resistance genetics
Humans
Malaria, Falciparum drug therapy
Malaria, Falciparum parasitology
Melanesia
Parasites drug effects
Plasmodium falciparum drug effects
Plasmodium vivax drug effects
Genes, Protozoan genetics
Parasites genetics
Plasmodium falciparum genetics
Plasmodium vivax genetics
Polymorphism, Genetic genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 63
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 31036683
- Full Text :
- https://doi.org/10.1128/AAC.00536-19